Synthetic biodegradable polymers as drug delivery systems for bone morphogenetic proteins

Adv Drug Deliv Rev. 2005 May 25;57(7):1037-48. doi: 10.1016/j.addr.2004.12.016. Epub 2005 Apr 15.


Bone morphogenetic proteins (BMP) induce bone formation in vivo, and clinical application in repair of bone fractures and defects is expected. However, appropriate systems to deliver BMP for clinical use need to be developed. We synthesized a new synthetic biodegradable polymer, poly-D,L-lactic acid-para-dioxanone-polyethylene glycol block copolymer (PLA-DX-PEG), to serve as a biocompatible, biodegradable polymer for recombinant human (rh) BMP-2 delivery systems. In animal experiments, new bone was efficiently formed and a large bone defect was repaired using PLA-DX-PEG/rhBMP-2 composites. In addition, this new polymer could be used as an injectable delivery system for rhBMP-2. The rhBMP-2/PLA-DX-PEG composites also could be combined with other materials such as hydroxyapatite or titanium. This new synthetic polymer might be used for rhBMP-2 delivery in various clinical situations involving repair of bone, leading to great changes in orthopedic treatment.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Bone Diseases / drug therapy*
  • Bone Diseases / therapy
  • Bone Morphogenetic Proteins / administration & dosage
  • Bone Morphogenetic Proteins / therapeutic use*
  • Drug Carriers
  • Injections, Intramuscular
  • Joint Prosthesis
  • Lactates / chemical synthesis
  • Lactates / chemistry*
  • Polyethylene Glycols / chemical synthesis
  • Polyethylene Glycols / chemistry*
  • Recombinant Proteins / administration & dosage
  • Recombinant Proteins / therapeutic use


  • Bone Morphogenetic Proteins
  • Drug Carriers
  • Lactates
  • Recombinant Proteins
  • poly(lactic acid-ethylene glycol)
  • polylactic acid-dioxanone-polyethylene glycol block copolymer
  • Polyethylene Glycols